Bright Minds Biosciences IncDRUG
Price$49.21

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 30 Sep 2024
Market Price $49.21Price as of 1 Oct 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 6.1%
Volatility vs market (adjusted beta)0.26

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetBright Minds Biosciences IncDRUGHealth Care
Valuation
P/E—
P/S—
P/B47.5×
EV / Revenue—
EV / EBITDA—
Profitability
Gross margin—
Operating margin—
Net margin—
FCF margin—
Returns
ROE-50.6%
ROA-45.9%
ROIC—
Growth
Revenue growth (YoY)—
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.03×
Current ratio11.32×
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.